-
Dr Reddy’s shares plummet 4.4% in the wake of logging modest Q3 growth
24 Jan 2025 06:09 GMT
The shares of Dr Reddy’s Laboratories … a voluntary licensing agreement with Gilead Sciences to manufacture an HIV treatment … by splitting existing ₹5 shares into five ₹1 shares.
Comments
SHARE
Copy …
-
Gilead Sciences: 2025 Preview, A Buy Thanks To Thriving HIV Franchise
29 Dec 2024 15:02 GMT
… The last time I covered Gilead Sciences (NASDAQ:GILD) for Seeking Alpha … beneficial long position in the shares of GILD either through stock …
-
Gilead Sciences invests $20.1 million in Assembly Biosciences
24 Dec 2024 04:20 GMT
… , by purchasing 940,499 shares of common stock. According … now holds 2,209,471 shares in Assembly Biosciences. This … strides in its collaboration with Gilead Sciences. The companies have amended … Biosciences, acquiring 940,499 shares of common stock.
In …
-
Gilead Sciences acquires $1.83 million in Xilio Therapeutics stock
19 Dec 2024 22:02 GMT
In a recent transaction, Gilead Sciences, Inc. (NASDAQ:GILD) expanded … a significant number of shares. The biopharmaceutical giant acquired … approximately 1,759,978 shares of Xilio's … Xilio's outstanding shares.
Following these transactions, Gilead …
-
Why FedEx Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
20 Dec 2024 11:25 GMT
… million of its shares was acquired by Gilead Sciences.
ZJK Industrial Co … Losers
Molecular Templates, Inc. MTEM shares tumbled 49.5% to $0 … .
Cara Therapeutics, Inc. CARA shares fell 26.7% to $0 … pre-market trading. Mesoblast shares jumped over 36% on Thursday …
-
Gilead Sciences Announces Third Quarter 2024 Financial Results
06 Nov 2024 21:07 GMT
… the accompanying tables.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical … , including the following: GILEAD®, GILEAD SCIENCES®, KITETM, AMBISOME®, ATRIPLA®, BIKTARVY … ,246 shares of common stock issued and outstanding.
GILEAD SCIENCES, INC …
-
Gilead Sciences's Earnings: A Preview
05 Nov 2024 15:24 GMT
… -3.0%
Performance of Gilead Sciences Shares
Shares of Gilead Sciences were trading at $89 … insights on Gilead Sciences.
The consensus rating for Gilead Sciences is Neutral, … .
Delving into Gilead Sciences's Background
Gilead Sciences develops and markets …
-
Lupin shares in focus after FDA approval for generic HIV tablets
19 Dec 2024 03:53 GMT
Shares of Lupin will remain in … mg/25 mg of Gilead Sciences, Inc," Lupin said in … , a product originally developed by Gilead Sciences Inc. Lupin is one of … to 20%
On Wednesday, Lupin shares closed at Rs 2,098 …
-
NuCana (NCNA) Shares Fall After Suing Gilead Sciences (GILD) in Germany Over Patent Infringement
21 Oct 2024 12:55 GMT
… after the British company sued Gilead Sciences ( GILD ) in Germany, alleging patent … and relation combination drugs. NCNA shares were down 2.64% to … ? NuCana ( NCNA ) sued Gilead Sciences Ireland UC and Gilead Sciences GmbH in the German …
-
This Gilead Sciences Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
17 Oct 2024 13:10 GMT
… target of $17. Grocery Outlet shares closed at $16.45 on … Aaron Gal initiated coverage on Gilead Sciences, Inc. GILD with an … a price target of $105. Gilead Sciences shares closed at $85.82 on … of $20. First Watch Restaurant shares closed at $14.77 on …